David Isenberg
Has participated in:
-
Autoimmune aspects of lung disease
-
“Mixed connective tissue disease”: a condition in search of an identity
-
Thioredoxin is a metabolic rheostat controlling regulatory B cells
-
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE